- Home
- INDP vs QNTM Comparison
INDP vs QNTM Comparison
Compare INDP & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- QNTM
- Stock Information
- Founded
- INDP 2000
- QNTM 1998
- Country
- INDP United States
- QNTM Canada
- Employees
- INDP N/A
- QNTM N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- QNTM
- Sector
- INDP Health Care
- QNTM
- Exchange
- INDP Nasdaq
- QNTM NYSE
- Market Cap
- INDP 7.4M
- QNTM 8.7M
- IPO Year
- INDP N/A
- QNTM N/A
- Fundamental
- Price
- INDP $0.45
- QNTM $10.25
- Analyst Decision
- INDP Strong Buy
- QNTM
- Analyst Count
- INDP 2
- QNTM 0
- Target Price
- INDP $8.50
- QNTM N/A
- AVG Volume (30 Days)
- INDP 43.0K
- QNTM 108.5K
- Earning Date
- INDP 05-14-2025
- QNTM 05-06-2025
- Dividend Yield
- INDP N/A
- QNTM N/A
- EPS Growth
- INDP N/A
- QNTM N/A
- EPS
- INDP N/A
- QNTM N/A
- Revenue
- INDP N/A
- QNTM N/A
- Revenue This Year
- INDP N/A
- QNTM N/A
- Revenue Next Year
- INDP N/A
- QNTM N/A
- P/E Ratio
- INDP N/A
- QNTM N/A
- Revenue Growth
- INDP N/A
- QNTM N/A
- 52 Week Low
- INDP $0.43
- QNTM $2.70
- 52 Week High
- INDP $3.10
- QNTM $25.35
- Technical
- Relative Strength Index (RSI)
- INDP 44.18
- QNTM 68.31
- Support Level
- INDP $0.36
- QNTM $7.96
- Resistance Level
- INDP $0.48
- QNTM $9.45
- Average True Range (ATR)
- INDP 0.05
- QNTM 0.77
- MACD
- INDP 0.01
- QNTM 0.17
- Stochastic Oscillator
- INDP 59.80
- QNTM 96.94
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.